 Monica Campbell
Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 9 | 2022 | 2066 | 0.550 |
Why?
| | Immunoglobulin E | 6 | 2021 | 328 | 0.450 |
Why?
| | Dermatitis, Atopic | 3 | 2021 | 310 | 0.430 |
Why?
| | Kaposi Varicelliform Eruption | 2 | 2021 | 24 | 0.360 |
Why?
| | Genetic Predisposition to Disease | 8 | 2021 | 2125 | 0.320 |
Why?
| | Genotype | 5 | 2021 | 1786 | 0.320 |
Why?
| | Schistosoma japonicum | 2 | 2019 | 33 | 0.290 |
Why?
| | Schistosomiasis japonica | 2 | 2019 | 34 | 0.280 |
Why?
| | Polymorphism, Single Nucleotide | 7 | 2021 | 1918 | 0.240 |
Why?
| | Psychological Theory | 1 | 2023 | 96 | 0.210 |
Why?
| | Genome-Wide Association Study | 6 | 2021 | 1217 | 0.200 |
Why?
| | HLA-A2 Antigen | 1 | 2021 | 37 | 0.200 |
Why?
| | HLA-DQ beta-Chains | 1 | 2021 | 59 | 0.190 |
Why?
| | Dinoprostone | 1 | 2022 | 186 | 0.190 |
Why?
| | Nucleotide Transport Proteins | 1 | 2021 | 2 | 0.190 |
Why?
| | Herpesvirus 1, Human | 1 | 2021 | 78 | 0.180 |
Why?
| | Quantitative Trait Loci | 1 | 2021 | 313 | 0.170 |
Why?
| | Antibodies, Helminth | 1 | 2019 | 7 | 0.170 |
Why?
| | Antigens, Helminth | 1 | 2019 | 13 | 0.170 |
Why?
| | Interleukin-4 | 1 | 2019 | 209 | 0.160 |
Why?
| | Genetics, Population | 2 | 2010 | 192 | 0.160 |
Why?
| | Helminthiasis | 1 | 2017 | 11 | 0.140 |
Why?
| | Cognition | 1 | 2023 | 980 | 0.140 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2017 | 156 | 0.130 |
Why?
| | DNA Methylation | 1 | 2019 | 498 | 0.120 |
Why?
| | Interleukin-13 | 1 | 2015 | 126 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2017 | 621 | 0.110 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 238 | 0.110 |
Why?
| | Gene Frequency | 3 | 2021 | 485 | 0.100 |
Why?
| | Whole Genome Sequencing | 2 | 2021 | 100 | 0.090 |
Why?
| | Fatty Acid Desaturases | 1 | 2010 | 30 | 0.090 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2010 | 46 | 0.090 |
Why?
| | Geography | 1 | 2010 | 181 | 0.090 |
Why?
| | Lung | 1 | 2021 | 3672 | 0.080 |
Why?
| | Dietary Fats | 1 | 2010 | 289 | 0.080 |
Why?
| | Case-Control Studies | 4 | 2019 | 3022 | 0.070 |
Why?
| | Liver | 1 | 2015 | 1690 | 0.070 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 526 | 0.070 |
Why?
| | Humans | 16 | 2023 | 115587 | 0.070 |
Why?
| | Brazil | 2 | 2017 | 93 | 0.060 |
Why?
| | Haplotypes | 2 | 2017 | 457 | 0.060 |
Why?
| | Odds Ratio | 2 | 2017 | 962 | 0.060 |
Why?
| | Female | 9 | 2022 | 59913 | 0.050 |
Why?
| | Male | 9 | 2021 | 55949 | 0.050 |
Why?
| | Reaction Time | 1 | 2023 | 373 | 0.050 |
Why?
| | Eicosanoids | 1 | 2022 | 55 | 0.050 |
Why?
| | Barbados | 2 | 2013 | 10 | 0.050 |
Why?
| | Epigenomics | 1 | 2022 | 105 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2022 | 94 | 0.050 |
Why?
| | Colombia | 2 | 2013 | 36 | 0.050 |
Why?
| | Americas | 1 | 2021 | 20 | 0.050 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 95 | 0.050 |
Why?
| | Spain | 1 | 2021 | 34 | 0.050 |
Why?
| | Peru | 1 | 2021 | 55 | 0.050 |
Why?
| | Glutathione Transferase | 1 | 2021 | 95 | 0.050 |
Why?
| | Middle Aged | 6 | 2021 | 26999 | 0.050 |
Why?
| | HLA-DQ Antigens | 1 | 2021 | 177 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2578 | 0.040 |
Why?
| | Adult | 6 | 2021 | 30718 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2019 | 21 | 0.040 |
Why?
| | CpG Islands | 1 | 2019 | 118 | 0.040 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2019 | 33 | 0.040 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2019 | 57 | 0.040 |
Why?
| | Young Adult | 3 | 2021 | 10470 | 0.040 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 157 | 0.040 |
Why?
| | China | 1 | 2019 | 163 | 0.040 |
Why?
| | Th2 Cells | 1 | 2019 | 157 | 0.040 |
Why?
| | Rabbits | 1 | 2019 | 752 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 264 | 0.040 |
Why?
| | Pilot Projects | 1 | 2022 | 1377 | 0.040 |
Why?
| | Eosinophils | 1 | 2019 | 282 | 0.040 |
Why?
| | Child | 3 | 2021 | 18488 | 0.030 |
Why?
| | Skin Tests | 1 | 2017 | 130 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 17889 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 9133 | 0.030 |
Why?
| | Aged | 3 | 2021 | 19251 | 0.030 |
Why?
| | Interleukin-10 | 1 | 2017 | 299 | 0.030 |
Why?
| | Host-Parasite Interactions | 1 | 2015 | 97 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 794 | 0.030 |
Why?
| | United States | 2 | 2021 | 12295 | 0.030 |
Why?
| | Jamaica | 1 | 2013 | 2 | 0.030 |
Why?
| | District of Columbia | 1 | 2013 | 25 | 0.030 |
Why?
| | New York | 1 | 2013 | 109 | 0.030 |
Why?
| | Molecular Epidemiology | 1 | 2013 | 66 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2264 | 0.030 |
Why?
| | Risk | 1 | 2015 | 819 | 0.030 |
Why?
| | Cohort Studies | 1 | 2021 | 4944 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1122 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3364 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1435 | 0.020 |
Why?
| | Multigene Family | 1 | 2010 | 193 | 0.020 |
Why?
| | Isoenzymes | 1 | 2010 | 285 | 0.020 |
Why?
| | Chromosomes, Human, Y | 1 | 2009 | 14 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 606 | 0.020 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2010 | 124 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3466 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2009 | 137 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2418 | 0.020 |
Why?
| | Genetic Markers | 1 | 2009 | 325 | 0.020 |
Why?
| | Risk Factors | 2 | 2013 | 8697 | 0.020 |
Why?
| | DNA, Mitochondrial | 1 | 2009 | 185 | 0.020 |
Why?
| | Social Class | 1 | 2009 | 210 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2009 | 732 | 0.020 |
Why?
| | Animals | 2 | 2019 | 32102 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1490 | 0.020 |
Why?
| | Indians, North American | 1 | 2009 | 584 | 0.010 |
Why?
|
|
Campbell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|